Matthew T Stier

5PUBLICATIONS
31CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Chemical engineering designApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 12, 2026
Critical illness expands a transcriptionally distinct hypometabolic CD8<sup>+</sup> T effector program associated with respiratory failure and mortality.

|Jan 16, 2026
Metabolic adaptations rewire CD4<sup>+</sup> T cells in a subset-specific manner in human critical illness with and without sepsis.

Matthew T Stier, Allison E Sewell, Erin L Mwizerwa

|Jan 03, 2026
Genetic diversity of Collaborative Cross mice implicates FFAR3 as a target for ILC2 anti-inflammatory reprogramming.

Mark Rusznak, Shinji Toki, Yajing Hao

|Feb 20, 2025
Metabolic Adaptations Rewire CD4 T Cells in a Subset-Specific Manner in Human Critical Illness with and without Sepsis.

Matthew T Stier, Allison E Sewell, Erin L Mwizerwa

|Mar 31, 2023
Immune characterization of a xenogeneic human lung cross-circulation support system.

Wei K Wu, Matthew T Stier, John W Stokes

Pageof 1

Frequent Collaborators

3 joint publications

Lorraine B Ware

3 joint publications

Jeffrey C Rathmell

2 joint publications

Julie A Bastarache

2 joint publications

Casey M Nichols